Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Active Participation

Jan 28, 2020/Perspective

Active participation within your section of interest is an important part of the APTA experience.

COVID-19 Core Outcome Measures

Jun 29, 2020/Open Access

Cross-academy/section task forces have identified two sets of core outcome measures for patients diagnosed with COVID-19, one for adults and one for children.

Complex Regional Pain Syndrome: Practical Diagnostic and Treatment Guidelines, 5th Edition

Nov 30, 2017/CPG

This comprehensive guideline, sponsored by the Reflex Sympathetic Dystrophy Syndrome Association, includes a section on physical therapy management as well as general considerations.

Student Spotlight: The Academy of Neurologic Physical Therapy

Jul 20, 2020/Open Access

The mission of the Academy of Neurologic Physical Therapy is to empower its members to optimize movement system performance for those impacted by neurologic conditions.

New Member Benefit a One-Stop-Shop for Prior Authorization, UM Advocacy Tools

Mar 15, 2022/News

APTA and the Private Practice Section have collaborated to create SPARC — the State Payer Advocacy Resource Center.

CoHSTAR's Health Policy Research Focus to Live on Through Foundation

Jun 8, 2023/News

The Foundation for Physical Therapy Research will add to its funding portfolio when CoHSTAR winds down in 2025.

Student Spotlight: Academy of Pelvic Health Physical Therapy

Oct 20, 2020/Article

More than 3,500 PTs, PTAs and students belong to the Academy of Pelvic Health Physical Therapy.

PT Student Loan Repayment Bill Returns

Jul 26, 2023/News

The legislation would add PTs to the National Health Services Corps and expand the role of PTs in community health centers.

APTA Early-Career Dues Discount FAQs

Early-Career Dues is the way for you to save 50% (up to $270) off your national and chapter dues in your first year postgraduation.

Hauser Ambulation Index for Multiple Sclerosis

Sep 12, 2013/Test & Measure

Target population: People with multiple sclerosis (MS).